Loading...
Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice
Bortezomib, a first-in-class proteasome inhibitor, is a standard method of treatment in multiple myeloma. In the present study, the therapeutic effect of bortezomib was evaluated in an ulcerative colitis model induced by dextran sulfate sodium (DSS) in mice, and the mechanism of action was also inve...
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436237/ https://ncbi.nlm.nih.gov/pubmed/28487944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6524 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|